Siemens launches SPECT/CT system offering low dose and up to 64 slices

Siemens Healthineers has introduced the Symbia Pro.specta SPECT/CT system. Its capabilities include low dose CT of up to 64 slices, automatic SPECT motion correction for additional image clarity and an intuitive and automated workflow.

Symbia Pro.specta can be customised to accommodate a range of clinical examinations, patient types and department settings.

With the ability to fit into most existing SPECT rooms, Symbia Pro.specta can help providers transition from SPECT-only and early generation SPECT/CT systems.

At the heart of the system is myExam Companion, which has an intuitive user interface that eliminates manual and user-dependent SPECT/CT imaging workflow. myExam Companion provides automated tools to guide the user through the examination decision making process, from system and patient preparation via image acquisition and reconstruction to evaluation and post processing, so that departments can achieve consistent results more easily.

Data-driven motion correction automatically corrects for patient movement with the click of a button. Data-driven respiratory motion correction for cardiac examinations is available as an option.

Siemens GB&I business manager for molecular imaging Lawrence Foulsham said: “The Symbia Pro.specta extends functionality for SPECT imaging at all energy levels, while affording the user the capabilities of  utilising advanced CT technologies to enhance their SPECT/CT studies.”

Symbia Pro.specta can be tailored with specialised clinical tools for optimised imaging in cardiology, neurology, oncology, orthopaedics and more. Flexible detectors and an accessible design facilitate imaging for a range of patient types without compromising examination quality, patient comfort or staff efficiency. The scanner can also be used for either standalone diagnostic CT or SPECT imaging.

Published on page 6 of the August 2022 issue of RAD Magazine.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more